Literature DB >> 22365879

Antimicrobial activity of sulfonamides containing 5-chloro-2-hydroxybenzaldehyde and 5-chloro-2-hydroxybenzoic acid scaffold.

Martin Krátký1, Jarmila Vinšová, Marie Volková, Vladimír Buchta, František Trejtnar, Jiřina Stolaříková.   

Abstract

A series of novel sulfonamides containing 5-chloro-2-hydroxybenzaldehyde or 5-chloro-2-hydroxybenzoic acid scaffolds were designed, synthesized and characterized by IR, (1)H NMR and (13)C NMR. All ten target synthesized derivatives and starting sulfonamides were evaluated in vitro for the activity against Gram-positive and Gram-negative bacteria, fungi, Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium kansasii. The most active compound against methicillin-sensitive and methicillin-resistant Staphyloccoccus aureus was 5-chloro-N-{4-[N-(4,6-dimethylpyrimidin-2-yl)sulfamoyl]phenyl}-2-hydroxybenzamide with MIC 15.62-31.25 μmol/L. 4-Amino-N-(thiazol-2-yl)benzenesulfonamide and 4-(5-chloro-2-hydroxybenzylideneamino)-N-(thiazol-2-yl)benzenesulfonamide have shown the best activity against M. kansasii at the concentrations of 1-4 μmol/L. The efficacy against other strains was weaker and the studied derivatives exhibited almost none antifungal potency. Copyright Â
© 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22365879     DOI: 10.1016/j.ejmech.2012.01.060

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  9 in total

1.  N-acylated derivatives of sulfamethoxazole and sulfafurazole inhibit intracellular growth of Chlamydia trachomatis.

Authors:  Sania Marwaha; Hanna Uvell; Olli Salin; Anders E G Lindgren; Jim Silver; Mikael Elofsson; Asa Gylfe
Journal:  Antimicrob Agents Chemother       Date:  2014-02-24       Impact factor: 5.191

2.  Novel Sulfamethoxazole Ureas and Oxalamide as Potential Antimycobacterial Agents.

Authors:  Martin Krátký; Jiřina Stolaříková; Jarmila Vinšová
Journal:  Molecules       Date:  2017-03-28       Impact factor: 4.411

3.  Sulfadiazine Salicylaldehyde-Based Schiff Bases: Synthesis, Antimicrobial Activity and Cytotoxicity.

Authors:  Martin Krátký; Magdaléna Dzurková; Jiří Janoušek; Klára Konečná; František Trejtnar; Jiřina Stolaříková; Jarmila Vinšová
Journal:  Molecules       Date:  2017-09-19       Impact factor: 4.411

4.  Sulphamethazine derivatives as immunomodulating agents: New therapeutic strategies for inflammatory diseases.

Authors:  Hina Siddiqui; Haroon M Haniffa; Almas Jabeen; Atta-Ur -Rahman; M Iqbal Choudhary
Journal:  PLoS One       Date:  2018-12-19       Impact factor: 3.240

Review 5.  Synthetic approaches and pharmaceutical applications of chloro-containing molecules for drug discovery: A critical review.

Authors:  Wan-Yin Fang; L Ravindar; K P Rakesh; H M Manukumar; C S Shantharam; Njud S Alharbi; Hua-Li Qin
Journal:  Eur J Med Chem       Date:  2019-04-10       Impact factor: 6.514

6.  Design, synthesis, and biological evaluation of novel N 4 -substituted sulfonamides: acetamides derivatives as dihydrofolate reductase (DHFR) inhibitors.

Authors:  Essam M Hussein; Munirah M Al-Rooqi; Shimaa M Abd El-Galil; Saleh A Ahmed
Journal:  BMC Chem       Date:  2019-07-11

7.  4-Aminobenzoic Acid Derivatives: Converting Folate Precursor to Antimicrobial and Cytotoxic Agents.

Authors:  Martin Krátký; Klára Konečná; Jiří Janoušek; Michaela Brablíková; Ondřej Janďourek; František Trejtnar; Jiřina Stolaříková; Jarmila Vinšová
Journal:  Biomolecules       Date:  2019-12-19

8.  Potential antibacterial and antifungal activities of novel sulfamidophosphonate derivatives bearing the quinoline or quinolone moiety.

Authors:  Ismahene Bazine; Samira Bendjedid; Abbes Boukhari
Journal:  Arch Pharm (Weinheim)       Date:  2020-12-07       Impact factor: 4.613

9.  In Vivo Radioprotective Potential of Newly Synthesized Azomethine and Styrylquinoline Derivatives and a Natural Polyphenol: A Preliminary Study.

Authors:  Nevena Nikolova; Donika Ivanova; Zvezdelina Yaneva
Journal:  Life (Basel)       Date:  2022-02-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.